Jim Cramer assesses recent acquisitions in AbbVie and Bristol-Myers

In this video

Share

Jim Cramer assesses recent acquisitions in AbbVie and Bristol-Myers

Jim Cramer breaks down large acquisitions that AbbVie and Bristol-Myers recently made and explains why he's recommending AbbVie as a buy.
11:20
Fri, Sep 20 20197:35 PM EDT